Patents by Inventor Sandeep Pandita

Sandeep Pandita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390192
    Abstract: Provided herein are controlled release gastro retentive dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile.
    Type: Application
    Filed: October 12, 2021
    Publication date: December 7, 2023
    Inventors: Mayank JOSHI, Parag SHAH, Soumen PATTANAYEK, Divyang PATEL, Sandeep PANDITA
  • Publication number: 20230364075
    Abstract: Provided herein are controlled release multiparticulate dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Inventors: Mayank JOSHI, Parag SHAH, Soumen PATTANAYEK, Divyang PATEL, Sandeep PANDITA
  • Publication number: 20230022862
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: March 1, 2022
    Publication date: January 26, 2023
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Publication number: 20220296585
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: June 8, 2022
    Publication date: September 22, 2022
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Patent number: 11311488
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: April 26, 2022
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Publication number: 20210386673
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: June 10, 2021
    Publication date: December 16, 2021
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Patent number: 10275303
    Abstract: Techniques for running diagnostic rules across multiple nodes are disclosed. A root cause of an error occurring on a particular node is determined. A root cause of an error on the particular node is identified based on a metric corresponding to another node and/or based on a previously-reported error on another node. Additionally or alternatively, an error is predicted to occur on a particular node. The error is predicted based on a trend associated with a metric corresponding to another node.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: April 30, 2019
    Assignee: Oracle International Corporation
    Inventors: Lalatendu Patra, Mridhula N. Shetty, Rajiv Maheshwari, Ashwin K. Karkala, Sandeep Pandita
  • Publication number: 20170116061
    Abstract: Techniques for running diagnostic rules across multiple nodes are disclosed. A root cause of an error occurring on a particular node is determined. A root cause of an error on the particular node is identified based on a metric corresponding to another node and/or based on a previously-reported error on another node. Additionally or alternatively, an error is predicted to occur on a particular node. The error is predicted based on a trend associated with a metric corresponding to another node.
    Type: Application
    Filed: March 21, 2016
    Publication date: April 27, 2017
    Inventors: Lalatendu Patra, Mridhula N. Shetty, Rajiv Maheshwari, Ashwin K. Karkala, Sandeep Pandita
  • Patent number: 8631280
    Abstract: Systems and methods are described for diagnosing behavior of software components in an application server. The application server can comprise a plurality of components that process incoming requests. A diagnostics advisor can be deployed with the application server and can determine an efficiency and/or inefficiency of each of the components of the application server or other middleware system. The efficiency determined by computing a ratio of the number of requests that completed execution during a particular sampling time period to the number of requests that were received. The inefficiency is the ratio of the number of requests that are still being executed at the end of the sampling time period to the number of requests that were received. The diagnostics advisor employs the determined efficiency and/or inefficiency to diagnose a misbehavior or other problem of the components in the application server.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: January 14, 2014
    Assignee: Oracle International Corporation
    Inventors: Raji Sankar, Govinda Raj Sambamurthy, Rahul Goyal, Ashwin Kumar Karkala, Sandeep Pandita
  • Patent number: 8600725
    Abstract: A system and method for providing a static model map of behaviors in a middleware system, for use in identifying problems. In accordance with an embodiment, the system provides a view of the system which allows for analysis of the various components. Locations within the system where a request spends its time are categorized into either “wait” or “execution” locations. The components exhibit static behaviors which affect the response time and can be predefined for different types of components and analyzed independently. In turn the behaviors can be classified as either “wait” or “execution”, each of which can be considered aspects of a component. Each aspect of a component must satisfy the same efficiency/inefficiency as defined by the requirements on the system. An aspect that does not meet the criteria is considered a “problem aspect” and is analyzed further to find the cause of the problem.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: December 3, 2013
    Assignee: Oracle International Corporation
    Inventors: Raji Sankar, Govinda Raj Sambamurthy, Rahul Goyal, Apoorv Anand Vajpayee, Sandeep Pandita
  • Publication number: 20120185732
    Abstract: Systems and methods are described for diagnosing behavior of software components in an application server. The application server can comprise a plurality of components that process incoming requests. A diagnostics advisor can be deployed with the application server and can determine an efficiency and/or inefficiency of each of the components of the application server or other middleware system. The efficiency determined by computing a ratio of a number of requests that completed execution in the component during a particular sampling time period to the number of requests that were received by the component during the sampling time period. The inefficiency is the inverse of efficiency, i.e. it is a ratio of the number of requests that are still being executed by the one or more components at the end of the sampling time period to the number of requests that were received by the one or more components during the sampling time period.
    Type: Application
    Filed: January 19, 2011
    Publication date: July 19, 2012
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Raji Sankar, Govinda Raj Sambamurthy, Rahul Goyal, Ashwin Kumar Karkala, Sandeep Pandita
  • Publication number: 20120185232
    Abstract: A system and method for providing a static model map of behaviors in a middleware system, for use in identifying system problems. In accordance with an embodiment, the system provides a view of the system, such as a middleware system, which allows for analysis of the various components involved, such that analysis of one component does not affect the analysis of a second component. Locations within the middleware system where a particular request spends its time before returning a response are broadly categorized into either “wait” or “execution” locations. Irrespective of which request calls a component, the components exhibit the same behaviors which affect the response time of the request serviced. These exhibited behaviors are static and can be predefined for different types of components and analyzed independently of each other. In turn the behaviors can be similarly classified as either “wait” or “execution”, each of which can be considered aspects of a component.
    Type: Application
    Filed: January 19, 2011
    Publication date: July 19, 2012
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Raji Sankar, Govinda Raj Sambamurthy, Rahul Goyal, Apoorv Anand Vajpayee, Sandeep Pandita
  • Patent number: 7807195
    Abstract: The present invention relates to an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride and pharmaceutically acceptable excipients. More particularly, the present invention relates to an extended release composition in the form of mini-tablets which are incorporated in hard gelatin capsules.
    Type: Grant
    Filed: January 7, 2005
    Date of Patent: October 5, 2010
    Assignee: Alembic Limited
    Inventors: Sampad Bhattacharya, Rajesh Kshirsagar, Mayank Joshi, Sandeep Pandita
  • Publication number: 20050169985
    Abstract: The present invention relates to an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride and pharmaceutically acceptable excipients. More particularly, the present invention relates to an extended release composition in the form of mini-tablets which are incorporated in hard gelatin capsules.
    Type: Application
    Filed: January 7, 2005
    Publication date: August 4, 2005
    Inventors: Sampad Bhattacharya, Rajesh Kshirsagar, Mayank Joshi, Sandeep Pandita